Neelufar Mozaffarian - 29 Jul 2024 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
Director
Signature
/s/ Cindy R. Tahl, as Attorney-in-Fact
Issuer symbol
FATE
Transactions as of
29 Jul 2024
Net transactions value
$0
Form type
4
Filing time
31 Jul 2024, 18:01:44 UTC
Next filing
30 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FATE Stock Option (Right to Buy) Award $0 +80,000 $0.000000 80,000 29 Jul 2024 Common Stock 80,000 $5.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shall vest in 36 equal monthly installments after the grant date, subject to the Reporting Person's continuous service to the Issuer as of each such vesting date.